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Antitumor activityAbstract A series of novel unsymmetrical 1-hetaryl-4-(2-chloroquinolin-3-yl) azines 4–9 was selec-
tively synthesized in a three-step procedure starting from acetanilide (1). The molecular structures
of 4–9 were established by elemental analyses, spectral data, hybrid density functional theory (DFT)
and time-dependent density functional theory (TD-DFT) calculations. Molecular conformation
analysis for compounds 4–9, performed using DFT calculations utilizing the energy functional 3-
Parameter (Exchange), Lee, Yang and Parr (B3LYP) and the full-electron basis set Density Gauss
double-zeta with polarization functions (DGDZVP), on the synthesized azines considering the tor-
sion angles (h1, h2, h3) revealed 8 plausible conformers for each compound. Electronic and thermo-
dynamic properties including the dipole moment and the thermodynamic energy values of the
Frontier occupied and virtual molecular orbitals, HOMO and LUMO, respectively, were calculated
for the most stable conformer for each compound. Furthermore, TD-DFT calculations coupled
with the polarizable conductor calculation model (PCM), performed on the most stable conformers
in DMF to account for the solvent effect, revealed that the optical properties including kmax and
oscillator strength performed on the most stable conformers were in excellent agreement with the
experimental kmax and molar extinction coefﬁcient, which clearly validate the most stable molecular
conformers identiﬁed for compounds 4–9. Comparison of the biological results to the calculated
electronic and thermodynamic properties showed that the cytotoxicity is dependent on the low-lying
696 S. Bondock et al.ELUMO because compound 8 has the lowest ELUMO value and exhibited the greatest antitumor
activity.
ª 2015 TheAuthors. Production and hosting by Elsevier B.V. on behalf ofKing SaudUniversity. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Azines, 2,3-diazabuta-1,3-dienes (commonly known as bis-
Schiff bases), are a class of compounds that undergo a wide
variety of chemical processes and have been used as potential
substrates for crisscross cycloaddition reactions [1]. The two
imine bonds that make up the azine moiety can be considered
as polar acceptor groups oriented in opposite directions
because they are joined by an N-N bond [2]. The presence of
an azine bridge between two conjugated systems prevents elec-
tron delocalization occurring between the two systems, and
azines are therefore considered to be conjugation stoppers
[3]. Azines are versatile intermediate in heterocyclic synthesis
[4], and are useful in the generation of conducting materials
[5]. Some heterocyclic azines showed an excellent anti-leuke-
mia activity [6] and act as ﬂuorescent brightening agents and
photosensitizers [7]. Azines were also developed for use as
ion-selective optical sensors [8].
On the other hand, the diverse pharmacological properties
of quinoline and their derivatives attracted worldwide atten-
tion in the last few decades because of their wide occurrence
in natural products, and drugs [9]. Literature survey revealed
that ﬁve-to-six membered heterocyclic compounds bearing a
quinoline ring in a linear fashion were found to possess antimi-
crobial and anticancer activities [10,11].
Although symmetrical azines are readily synthesized by the
reaction of hydrazine with an excess of an aldehydes or
ketones, the preparation of their unsymmetrical azines is more
challenging [12]. Among the different published procedures for
the synthesis of unsymmetrical azines, a two-step procedure is
reported which involves (i) preparation of aldimines/ketimines
by condensation of hydrazine with aldehydes or ketones, (ii)
reaction of the resulting aldimines or ketimines with other car-
bonyl derivatives [13–15]. Recently, Safari et al. [16] reported
the one-step synthesis of unsymmetrical azines via condensa-
tion of aromatic aldehyde derivatives with hydrazine sulfate
in triethylamine and absolute ethanol solution.
Gaining deep insights into the structure–property and/or
structure–activity relationship of unsymmetrical azine analogs
4–9 presented in this study for conducting material, anti-leuke-
mia or photosensitizers require obtaining the correct molecular
geometry, which is the critical ﬁrst step in predicting electronic,
optical and thermodynamic properties and establishing struc-
ture–activity/property relationships. With the aforementioned
in mind, one of the key objectives in this study was to identify
the most stable conformer (equilibrium molecular geometry)
for each compound, using DFT calculations, of the synthe-
sized unsymmetrical azines 4–9 and validate that by comparing
the calculated optical properties including kmax and oscillator
strength, obtained from TD-DFT calculations, to the experi-
mental kmax and molar extinction coefﬁcient.
In the light of the above mentioned ﬁnding, we report herein
the synthesis, antitumor evaluation of some novel unsymmetri-
cal 1-hetaryl-4-(2-chloroquinolin-3-yl) azines (4–9) and acomprehensive DFT study of plausible conformers and identi-
fying the most stable conformer for each compound followed
by TD-DFT calculations to predict the optical properties.
2. Experimental
Melting points were determined on digital Gallen-Kamp
MFB-595 instrument using open capillary tubes and are
uncorrected. UV–Vis spectra were recorded on Shimadzu
UV-1800 spectrophotometer. IR spectra were recorded on Shi-
madzu FTIR 440 spectrometer using KBr pellets. Mass spectra
were performed on Shimadzu Qp-2010 plus mass spectrometer
at 70 eV. 1H-NMR and 13C-NMR spectra were recorded on a
Bruker model 500 MHz Ultra Shield NMR spectrometer in
DMSO-d6 using tetramethylsilane (TMS) as an internal stan-
dard; chemical shifts are reported as dppm units. The elemental
analyses were done at the Microanalytical Center, Cairo Uni-
versity, Cairo, Egypt. 2-Chloroquinoline-3-carbaldehyde (2)
[17], 2-chloroquinoline-3-carbaldehyde hydrazone (3) [10], 1-
(piperdin-1-ylmethyl)indoline-2,3-dione, and 1-(morpholinom-
ethyl)indoline-2,3-dione [18] were prepared according to the
literature procedures.
2.1. General procedure for the synthesis of unsymmetrical azines
4–9
A mixture of compound 2 (2.05 g, 0.01 mol) and appropriate
heterocyclic aldehydes or ketones (0.01 mol) in ethanol
30 mL was reﬂuxed for 4 h. The reaction mixture was allowed
to cool down to room temperature and the solid formed was
ﬁltered, washed with ethanol, dried, and recrystallized from a
mixture of EtOH/DMF (2:1) to afford azines 4–9.
2.1.1. 2-Chloroquinoline-3-carbaldehyde [(1E)-2-
furylmethylene]hydrazone (4)
Yellow powder, Yield (64%), mp > 300 C; IR (KBr)
mmax/cm
1: 3095 (CH-Ar), 1614 (C‚N), 1583 (C‚C, conju-
gated), 1049 (C-O), 774 (C-Cl); 1H-NMR (DMSO-d6):
dppm = 7.24 (t, J= 4 Quinoline-H7), 8.04 (Hz, 1H, Furan-
H4), 7.71 (t, J= 7 Hz, 1H, Quinoline-H6), 7.75 (d, J= 5 Hz,
1H, Furan-H3), 7.90 (d, J= 5 Hz, 1H, Furan-H5), 7.94
(t, J= 7 Hz, 1H, Quinoline-H7), 7.98 (d, J= 8 Hz, 1H, Quin-
oline-H8), 8.23 (d, J= 8 Hz, 1H, Quinoline-H5), 8.96 (s, 1H,
Quinoline-H4), 8.98 (s, 1H, CH‚N), 9.06 (s, 1H, CH‚N);
13C-NMR (DMSO-d6): dppm = 125.5 (Quinoline-C4a), 126.7
(Quinoline-C6), 127.6 (Furan-C5), 127.9 (Quinoline-C3),
128.5 (Furan-C4), 129.7 (Furan-C3), 132.0 (Quinoline-C8),
132.7 (Quinoline-C5), 134.7 (Quinoline-C4), 136.9 (Quinoline-
C7), 138.2 (Furan-C2), 147.7 (Quinoline-C8a), 149.0 (Quino-
line-C2), 156.7 (Furan-CH‚N), 157.6 (Quinoline-CH‚N).
MS m/z (%): 283 (M+, 1.8), 244 (1.3), 217 (1.4), 216 (7.6),
204 (1.5), 198 (4.0), 162 (14.1), 81 (9.7), 80 (100.0); Anal.
Calcd. for C15H10ClN3O (283.71): C, 63.50; H, 3.55; N,
14.81%, Found: C, 63.47; H, 3.48; N, 14.78%.
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thienylmethylene]hydrazone (5)
Yellow crystals, Yield (82%), mp 144–145 C; IR (KBr)
mmax/cm
1: 3110 (CH-Ar), 1611 (C‚N), 1589 (C‚C,
conjugated), 782 (C-Cl); 1H-NMR (DMSO-d6): dppm = 7.27
(t, J= 4 Hz, 1H, Thiophene-H4), 7.72 (t, J= 7 Hz, 1H,
Quinoline-H6), 7.76 (d, J= 5 Hz, 1H, Thiophene-H3), 7.89
(d, J= 5 Hz, 1H, Thiophene-H5), 7.92 (t, J= 7 Hz, 1H,
Quinoline-H7), 7.99 (d, J= 8 Hz, 1H, Quinoline-H8), 8.21
(d, J= 8 Hz, 1H, Quinoline-H5), 8.95 (s, 1H, Quinoline-H4),
8.99 (s, 1H, CH‚N), 9.07 (s, 1H, CH‚N); 13C-NMR
(DMSO-d6): dppm = 125.4 (Quinoline-C4a), 126.6 (Quinoline-
C6), 127. 7 (Thiophene-C5), 127.9 (Quinoline-C3), 128.4
(Thiophene-C4), 129.3 (Thiophene-C3), 131.9 (Quinoline-C8),
132.8 (Quinoline-C5), 134.8 (Quinoline-C4), 136.8 (Quinoline-C7),
137.9 (Thiophene-C2), 147.6 (Quinoline-C8a), 148.9 (Quino-
line-C2), 156.6 (Thiophene-CH‚N), 157.5 (Quinoline-
CH‚N). MS m/z (%): 299 (M+, 4.3), 264 (100), 216 (4.3),
190 (4.5), 162 (4.5), 111 (10.2), 110 (20.2), 82 (9.7); Anal.
Calcd. for C15H10ClN3S (299.78): C, 60.10; H, 3.36; N,
14.02%, Found: C, 60.05; H, 3.32; N, 14.00%.
2.1.3. 2-Chloroquinoline-3-carbaldehyde [(1E)-pyridin-3-
ylmethylene]hydrazone (6)
Yellow crystals, Yield (85%), mp 112–113 C; IR (KBr)
mmax/cm
1: 3060 (CH-Ar), 1614 (C‚N), 1584 (C‚C,
conjugated), 776 (C-Cl); 1H-NMR (DMSO-d6): dppm = 7.70
(t, J= 7 Hz, 1H, Quinoline-H6), 7.87 (dd, J= 8 Hz, 5 Hz,
1H, Pyridine-H5), 7.94 (t, J= 7 Hz, 1H, Quinoline-H7), 7.97
(d, J= 8 Hz, 1H, Quinoline-H8), 8.23 (d, J= 8 Hz, 1H,
Quinoline-H5), 8.75 (d, J= 5 Hz, 1H, Pyridine-H4), 8.88 (d,
J= 5 Hz, 1H, Pyridine-H6), 8.92 (s, 1H, Quinoline-H4), 8.97
(s, 1H, CH‚N), 9.12 (s, 1H, CH‚N), 9.31 (s, 1H, Pyridine-
H2);
13C-NMR (DMSO-d6): dppm = 125.5 (Quinoline-C4a),
126.5 (Quinoline-C6), 127.8 (Quinoline-C3), 129.5 (Pyridine-C5),
131.8 (Quinoline-C8), 132.9 (Quinoline-C5), 133.9 (Pyridine-
C3), 134.7 (Quinoline-C4), 136.9 (Quinoline-C7), 138.3
(Pyridine-C4), 143.2 (Pyridine-C2), 143.8 (C‚N), 147.7
(Quinoline-C8a), 148.9 (Quinoline-C2), 155.6 (Pyridine-C6),
158.0 (Pyridine-CH‚N), 159.4 (Quinoline-CH‚N). MS m/z
(%): 294 (M+, 2.6), 259 (100), 217 (0.8), 216 (1.9), 162 (3.9),
133 (7.8), 132 (90.8), 105 (12.4), 78 (24.9); Anal. Calcd. for
C16H11ClN4 (294.74): C, 65.20; H, 3.76; N, 19.01%, Found:
C, 65.17; H, 3.71; N, 19.04%.
2.1.4. 2-Chloroquinoline-3-carbaldehyde [(3Z)-2-oxo-1,2-
dihydro-3H-indol-3-ylidene]-hydrazone (7)
Orange powder, Yield (86%), mp 277–278 C; IR (KBr)
mmax/cm
1: 3198 (NH), 3065 (CH-Ar), 1732 (C‚O), 1612
(C‚N), 1590 (C‚C, conjugated), 785 (C-Cl); 1H-NMR
(DMSO-d6): dppm = 6.94 (d, J= 8.0 Hz, 1H, Indolin-2-one-
H4), 7.05 (t, J= 7.5 Hz, 1H, Indolin-2-one-H5), 7.44
(t, J= 8.0 Hz, 1H, Quinoline-H6), 7.78 (t, J= 7.5 Hz, 1H,
Indolin-2-one-H6), 7.91 (d, J= 8.0 Hz, 1H, Indolin-2-one-
H7), 7.96 (t, J= 8.0 Hz, 1H, Quinoline-H7), 8.04 (d,
J= 8.5 Hz, 1H, Quinoline-H8), 8.34 (d, J= 8 Hz, 1H, Quin-
oline-H8), 8.84 (s, 1H, Quinoline-H4), 9.26 (s, 1H, CH‚N),
10.95 (s, 1H, NH); 13C-NMR (DMSO-d6): dppm = 110.9
(Indolin-2-one-C4a), 116.0 (Indolin-2-one-C7), 122.6 (Indolin-
2-one-C5), 125.0 (Quinoline-C4a), 126.8 (Quinoline-C6), 127.7
(Quinoline-C3), 128.0 (Quinoline-C8), 129.1 (Quinoline-C5),129.6 (Indolin-2-one-C4), 132.8 (Indolin-2-one-C6), 134.2
(Quinoline-C4), 138.4 (Quinoline-C7), 145.3 (Indolin-2-one-C3),
147.8 (Indolin-2-one-C7a), 148.9 (Quinoline-C8a), 149.9 (Quin-
oline-C2), 154.0 (C‚N), 164.2 (C‚O). MS m/z (%): 334 (M
+,
16.9), 306 (100), 299 (22.4), 173 (15.8), 163 (10.3), 162 (10.4),
145 (10.0), 120 (23.2), 77 (1.2); Anal. Calcd. for C18H11ClN4O
(334.76): C, 64.58; H, 3.31; N, 16.74%, Found: C, 64.52; H,
3.29; N, 16.71%.
2.1.5. 2-Chloroquinoline-3-carbaldehyde [(3Z)-2-oxo-1-
(piperidin-1-ylmethyl)-1,2-dihydro-3H-indol-3-ylidene]-
hydrazone (8)
Yellow powder, Yield (71%), mp 245–246 C; IR (KBr) mmax/
cm1: 3058 (CH-Ar), 1734 (C‚O), 1612 (C‚N), 1585 (C‚C,
conjugated), 776 (C-Cl); 1H-NMR (DMSO-d6): dppm = 1.45
(bs, 6H, Piperidine-3CH2), 2.51 (bs, 4H, Piperidine-2CH2),
4.35 (s, 2H, NCH2), 6.90 (d, J= 8.0 Hz, 1H, Indolin-2-one-
H4), 7.12 (t, J= 7.5 Quinoline-H7), 8.04 (Hz, 1H, Indolin-2-
one-H5), 7.41 (t, J= 8.0 Hz, 1H, Quinoline-H6), 7.81 (t,
J= 7.5 Hz, 1H, Indolin-2-one-H6), 7.92 (d, J= 8.0 Hz, 1H,
Indolin-2-one-H7), 7.98 (t, J= 8.0 Hz, 1H, Quinoline-H7),
8.12 (d, J= 8.5 Hz, 1H, Quinoline-H8), 8.37 (d, J= 8 Hz,
1H, Quinoline-H8), 8.86 (s, 1H, Quinoline-H4), 9.29 (s, 1H,
CH‚N); 13C-NMR (DMSO-d6): dppm = 25.3 (Piperidine-
C4), 27.5 (Piperdine-2C3,5), 52.9 (Piperidine-2C2,6), 69.3
(NCH2N), 111.2 (Indolin-2-one-C4a), 116.3 (Indolin-2-one-
C7), 122.4 (Indolin-2-one-C5), 125.4 (Quinoline-C4a), 126.9
(Quinoline-C6), 127.6 (Quinoline-C3), 128.2 (Quinoline-C8),
129.1 (Quinoline-C5), 129.8 (Indolin-2-one-C4), 132.6 (Indo-
lin-2-one-C6), 134.5 (Quinoline-C4), 138.6 (Quinoline-C7),
143.8 (C‚N), 145.5 (Indolin-2-one-C3), 147.6 (Indolin-2-
one-C7a), 148.6 (Quinoline-C8a), 149.7 (Quinoline-C2), 156.9
(CH‚N), 164.4 (C‚O). MS m/z (%): 431 (M+, 16.3), 397
(12.1), 379 (10.1), 345 (26.6), 344 (15.9), 322 (10.1), 307
(100), 218 (9.8), 190 (14.5), 162 (20.0), 128 (34.2), 99 (23.9),
98 (14.0), 54 (14.0); Anal. Calcd. for C24H22ClN5O (431.92):
C, 66.74; H, 5.13; N, 16.21%, Found: C, 66.69; H, 5.09; N,
16.18%.
2.1.6. 2-Chloroquinoline-3-carbaldehyde [(3Z)-2-oxo-1-
(morpholin-4-ylmethyl)-1,2-dihydro-3H-indol-3-ylidene]-
hydrazone (9)
Orange powder, Yield (61%), mp 280–281 C; IR (KBr) mmax/
cm1: 3045 (CH-Ar), 1732 (C‚O), 1611 (C‚N), 1590 (C‚C,
conjugated), 778 (C-Cl); 1H-NMR (DMSO-d6): dppm = 2.54
(m, 4H, Morpholine-2CH2), 3.96 (m, 4H, Morpholine-
2CH2), 4.45 (s, 2H, NCH2), 6.89 (d, J= 8.0 Hz, 1H, Indo-
lin-2-one-H4), 7.14 (t, J= 7.5Hz, 1H, Indolin-2-one-H5),
7.39 (t, J= 8.0 Hz, 1H, Quinoline-H6), 7.84 (t, J= 7.5 Hz,
1H, Indolin-2-one-H6), 7.88 (d, J= 8.0 Hz, 1H, Indolin-2-
one-H7), 7.96 (t, J= 8.0 Hz,1H, Quinoline-H7), 8.09 (d,
J= 8.5 Hz, 1H, Quinoline-H8), 8.41 (d, J= 8 Hz, 1H, Quin-
oline-H8), 8.87 (s, 1H, Quinoline-H4), 9.28 (s, 1H, CH‚N);
13C-NMR (DMSO-d6): dppm = 28.1 (Morpholine-2C), 54.5
(Morpholine-2C), 69.5 (NCH2N), 111.4 (Indolin-2-one-C4a),
115.9 (Indolin-2-one-C7), 122.6 (Indolin-2-one-C5), 125.7
(Quinoline-C4a), 127.0 (Quinoline-C6), 127.8 (Quinoline-C3),
128.3 (Quinoline-C8), 129.4 (Quinoline-C5), 130.1 (Indolin-2-
one-C4), 132.5 (Indolin-2-one-C6), 134.8 (Quinoline-C4),
138.4 (Quinoline-C7), 143.7 (C‚N), 145.7 (Indolin-2-one-
C3), 147.9 (Indolin-2-one-C7a), 148.8 (Quinoline-C8a), 150.1
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434 (M++1, 22.5), 433 (M+, 21.6), 381 (4.8), 348 (17.4),
347 (6.8), 296 (25.4), 186 (17.7), 163 (0.3), 152 (100), 87 (9.6),
54 (4.2); Anal. Calcd. for C23H20ClN5O2 (433.89): C, 63.67;
H, 4.65; N, 16.14%, Found: C, 63.55; H, 4.61; N, 16.11%.
2.1.7. Alternative method for the synthesis of Mannich bases 8
and 9
The Schiff base 7 (0.67 g, 0.002 mol) was dissolved in absolute
ethanol (30 mL). Then formaldehyde (37%, 0.5 mL) and each
of piperidine (0.002 mol) or morpholine (0.002 mol) were
added dropwise with vigorous stirring. After combining all
reagents, the reaction mixture was stirred at room temperature
for 12 h. The mixture was cooled; the solid product was ﬁltered
and washed with petroleum ether. The solid that separated was
recrystallized from ethanol-DMF (2:1) to yield the title com-
pounds 8 and 9.
3. Results and discussion
3.1. Chemistry
The target unsymmetrical azines were synthesized in a three-
step procedure as depicted in Scheme 1. The ﬁrst step involves
the synthesis of 2-chloroquinoline-3-carbaldehyde (2) from
acetanilide 1 via a Vilsmeier-Haack reaction as previously
reported by Meth-Cohn and coworkers [17]. Compound 2
possesses two electrophilic sites, chlorine atom at C-2 and
the formyl group at C-3, with reactivity order C-3 > C-2.
Condensation of equimolar amounts of aldehyde 2 with hydra-N Cl
CHO
2
NH2NH2
EtOH
N Cl
3
N
NH2
O CHO
EtOH
S CHO
EtOH
N
CHO
EtOH
N
H
O
O
EtOH
N
O
O
N
EtOH
NHCOCH3
POCl3 / DMF
75 0C, 18h
1
Scheme 1 Synthesis of unzine hydrate in warming ethanol at 70 C afforded the aldim-
ine 3 rather than the expected 1H-pyrazolo [3,4-b] quinoline
[10]. The reactivity of the terminal amino group of aldimine
3 toward some heterocyclic aldehydes and ketones was investi-
gated as a possible synthetic route to attain unsymmetrical
azines. Thus, condensation of aldimine 3 with a series of het-
erocyclic aldehydes, namely, furfural, 2-formylthiophene and
3-formylpyridine, in reﬂuxing ethanol, afforded, in each case,
a sole product, identiﬁed as unsymmetrical azines 4–6. Elemen-
tal analyses and spectral data (FT-IR, MS, 1H and 13C-NMR)
conﬁrmed the structure of the latter products. The FT-IR spec-
trum of azine 5, as a representative example, showed strong
absorption bands at 1611 and 1589 cm1 due to a conjugated
C‚N and C‚C functions, respectively. Its 1H-NMR spec-
trum revealed, in addition to expected aromatic signals, three
singlet signals at d 8.95, 8.99, 9.07 ppm assignable to the pro-
ton of quinoline-H4 and two protons of the azomethine
(CH‚N), respectively. In addition, the 13C-NMR spectrum
of 5 displayed two characteristic peaks for two imine carbons
at d 156.6 and 157.5 ppm among a total of 15 carbon signals.
Moreover, the mass spectrum of 5 revealed a molecular ion
peak at m/z 299 (M+) corresponding to a molecular formula
(C15H10ClN3S).
In a similar manner, compound 3 reacted with heterocyclic
ketones, namely, isatin, 1-(piperdin-1-ylmethyl)indoline-2,3-
dione, and 1-(morpholinomethyl)indoline-2,3-dione, in boiling
ethanol, to afford the respective unsymmetrical azines 7–9. The
mass spectra of the latter products showed, in each case, their
molecular ion peaks. The FT-IR spectrum of unsymmetrical
azine 7 revealed absorption bands at 3198, 1732, 1612, and
1590 cm1 characteristic for NH, C‚O, C‚N, and C‚CN Cl
4
N
N O
N Cl
5
N
N S
N Cl
6
N
N
N
N Cl
7
N
N
NH
O
X
N Cl
8, X = CH
9, X = O
N
N
N
O N
X
CH2=O,
HN
X
EtOH
symmetrical azines 4–9.
Table 1 Calculated energy, HOMO/LUMO and dipole moment for the most stable conformers of compounds 4–9 calculated using
DFT (B3LYP/DGDZVP).
Most stable conformers 4 5 6 7 8 9
E (kcal/mol) 1112544.99 1090015.49 908009.66 812958.23 1004150.91 801504.08
Dipole moment (Dyebe) 4.0445 6.5524 4.6258 2.0983 4.5046 3.5989
HOMO (Hartree) 0.22576 0.22831 0.24177 0.23618 0.22805 0.23355
LUMO (Hartree) 0.09832 0.09908 0.10390 0.10356 0.11278 0.10261
1 Hartree = 27.211 eV.
N Cl
N
N O
θ 1 θ 2 θ 3
N Cl
N
N S
θ 1 θ 2 θ 3
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N
N
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N Cl
N
N
NH
O
θ 1 θ 2
N Cl
8, X = CH
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Figure 1 Plausible conformers for compounds 4–9.
4 5
6
7
8 9
Figure 2 Equilibrium molecular geometry of the most stable conformers for compounds 4–9.
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700 S. Bondock et al.functions, respectively. The 1H-NMR spectrum of 7 showed, in
addition to aromatic signals, D2O-exchangable signal at d 10.95
assignable to NH proton, and a singlet signal at 9.26 ppm
attributable to the azomethine proton (CH‚N). Its
13C-NMR spectrum revealed 18 carbon types, the most
important signals being displayed at d 164.2 and 154.0 ppm
speciﬁc for carbonyl and azomethine carbons, respectively.
Additionally, the elucidation of structures 8 and 9 was sup-
ported chemically through their alternative synthesis from the4
5
6
7
8
9
Figure 3 Calculated isodensity of Frontier occupied (left) and
virtual (right) molecular orbitals for the most stable conformers of
compounds 4–9. HL-42 (isodensity value = 0.02).respective Mannich reactions of unsymmetrical azine 7 with,
each of, formalin and piperidine, and formalin and morpholine.
3.2. Molecular modeling
Conformation studies of compounds 4–9 were performed
using the energy functional 3-Parameter (Exchange), Lee,
Yang and Parr (B3LYP) [19,20] and the full-electron basis
set Density Gauss double-zeta with polarization functions
(DGDZVP) [21,22]. Due to the high degree of freedom in some
of these compounds including 5–7, there can be up to 16 plau-
sible conformers when rotations around all bonds are consid-
ered (24). However, only the torsion angles (h1, h2, h3) around
the freely rotating sigma bonds are considered as they lead to
the most stable conformers. For each torsion angle (h), two
conformers were considered where either h= 0 or 180.
Hence, for compounds 4–6, eight possible conformers were
identiﬁed for each (23 = 8). Although for compound 7 only
two torsion angles around the freely rotating single bonds were
considered, plausible tautomerization to enol and keto forms
gave rise to a total of eight conformers. The total energy for
all possible conformers was calculated and the most stable con-
former was identiﬁed for each compound and is presented in
Table 1. Moreover, electronic and thermodynamic properties
such as dipole moment and the energy values corresponding
to Frontier occupied (HOMO) and virtual (LUMO) molecular
orbitals were also calculated for the most stable conformer for
each compound and are presented in Table 1. Fig. 1 shows the
molecular structures with the torsion angles that give rise to
plausible conformers for each compound, and Fig. 2 shows
the equilibrium molecular geometry identiﬁed for the most sta-
ble conformers for compounds 4–9.
Fig. 3 shows the Frontier occupied and virtual molecular
orbital density surface for the most stable conformers of com-
pounds 4–9 with isodensity at 0.02. The location and the size
of theHOMO/LUMO lobes for compounds 4–7 clearly indicate
that there is a strong HOMO–LUMO overlap throughout the
named compounds, a feature that indicates that these com-
pounds are likely to exhibit strong charge transfer, and therefore
are likely to be good photosensitizers. However, for compounds
8–9, the size of the HOMO lobes located on the quinoline moi-
ety was signiﬁcantly smaller than that of compounds 4–7.
To further validate the most stable molecular conformer
identiﬁed for each compound, time-dependent density func-
tional utilizing the same energy functional B3LYP and the
basis set were performed on the equilibrium molecular geome-
try of the most stable conformer for each compound and the
calculated vertical electronic excitation and oscillator strengthTable 2 Comparison of the experimental and calculated TD-
DFT (B3LYP/DGDZVP) absorption spectra.
Compd. Experimental (DMF) Calculated (DMF)
e (M1 cm1) kmax (nm) kmax Oscillator strength
4 32,000 395 397 1.14
5 31,000 391 392 1.17
6 28,000 368 367 1.12
7 26,000 341 340 0.44
8 25,000 388 389 0.464
9 19,000 342 343 0.343
Table 3 Cytotoxicity (IC50) of tested azines 4–9 on different cell lines.
Compd. no. IC50 (lg/mL)
MCF-7 NCI-H460 SF-268 WI-38
4 32.22 ± 2.44 32.40 ± 4.56 26.62 ± 8.91 27.32 ± 4.59
5 39.42 ± 5.28 6.42 ± 1.20 28.81 ± 4.84 44.86 ± 6.51
6 4.82 ± 1.05 8.13 ± 1.26 5.68 ± 1.42 40.54 ± 4.85
7 44.52 ± 6.86 32.40 ± 3.36 48.39 ± 4.84 >100
8 0.02 ± 0.006 0.01 ± 0.008 0.06 ± 0.008 >100
9 2.2 ± 1.22 18.25 ± 2.69 4.21 ± 1.50 72.6 ± 4.29
Doxorubicin 0.04 ± 0.008 0.09 ± 0.008 0.09 ± 0.007 >100
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coefﬁcient, respectively. Table 2 shows the experimental versus
the calculated (DFT) kmax. The calculated oscillator strength
was consistent with the order of the experimental molar extinc-
tion coefﬁcient. Moreover, the calculated kmax for compounds
4–6 were in excellent agreement with the experimental kmax,
which conﬁrms that the equilibrium molecular geometry
shown in Fig. 2 is indeed of the most stable conformers.
3.3. Antitumor evaluation
The cytotoxic effects of the novel azines 4–9 against a panel of
four human tumor cell lines namely; breast cancer (MCF-7),
non-small cell lung (NCI-H460), central nervous system (SF-
268), and lung ﬁbroblasts WI-38 were evaluated at the
National Institute of Cancer, Cairo, Egypt. The method
applied is similar to that reported by Skehan and Storeng
[23] using Sulfo-Rhodamine-B stain (SRB). Doxorubicin was
used as a reference to evaluate the potency of the investigated
compounds. The results are given in Table 3. As shown in
Table 3, azine 8 has unpredictable antitumor activity against
three human tumor cell lines MCF-7, NCI-H460, and SF-
268 as its IC50 value is 0.02, 0.01, and 0.06 lg/mL, respectively,
which is more potent than that of the reference Doxorubicin.
Azines 4–7 and 9 showed, however, less activity than that of
azine 8. This ﬁnding indicates that substitution of isatinyl azine
with piperidine moiety enhanced the amphiphilic properties
and solubility and, hence, the penetration of compound 8 into
the cell wall of malignant cells, which translated into better
antitumor activity.
Furthermore, from the comparison of the biological results
and the calculated electronic and thermodynamic properties, it
can be seen clearly that there is a reasonable correlation
between the cytotoxicity and the energy value of the lowest
unoccupied molecular orbital (ELUMO) as evident by the great-
est cytotoxicity of compound 8. This clearly indicates that the
lowest-lying ELUMO value of compound 8 is the most thermo-
dynamically favorable excited state for interaction with the
EHOMO of the receptor protein (electron rich center), which
led to the most effective antitumor activity. Hence, to avoid
the shotgun approach, molecular screening can be performed
where thermodynamic molecular descriptors such HOMO
and LUMO of compounds can be predicted prior to synthesis
to identify the most effective antitumor compound, which
would save money, time and effort. It is worthwhile to mention
that the order of the activity of azine 8 against tumor cell lines
is NCI-H460 >MCF-7 > SF-268 >WI-38.4. Conclusions
In conclusions, the objectives of the present study were to syn-
thesize some novel unsymmetrical azines and to perform a con-
formational analysis using DFT to identify the most stable
conformer for each compound and subsequently perform
TD-DFT to calculate its electronic, thermodynamic and opti-
cal properties to validate the most stable conformers. Calcu-
lated optical properties including kmax and oscillator strength
obtained from TD-DFT calculations, performed on the most
stable conformer for each compound, were in excellent agree-
ment with the experimental kmax and molar extinction coefﬁ-
cient, respectively. It was also found that the cytotoxicity is
dependent on the low-lying ELUMO because compound 8 has
the lowest ELUMO value and exhibited the greatest antitumor
activity. Hence, in this study we developed a novel approach
of conﬁrming the molecular conformer pertaining to each
molecular structure using high level DFT/TD-DFT calcula-
tions utilizing the energy functional B3LYP and the basis set
DGDZVP, which can be used as a screening tool of electronic,
optical and thermodynamic properties for existing and novel
unsymmetrical azine analogs, and that would pave the way
for future development of more effective unsymmetrical azine
analogs for biological and material applications.
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